Life Science Compliance Update

December

2015

December 2015: Life Science Compliance Update

Written by , Posted in December 2015 LSC, This Month in Compliance

The full text of the entire issue is now available to our subscribers. If you are a subscriber please log in now. You may also buy this issue by clicking on the button below.

October 2015 LSCU Cover

Issue Summary

The fall season has been a particularly busy season for compliance, and the December issue of the Life Science Compliance Update reflects that. This month’s issue focuses on enforcement and the Government’s new push for individual accountability. We have articles on the Yates Memo with insights on it from Paul Kalb of Sidley Austin, as well as how the DOJ, FBI and OIG view it. In addition, we review both the new Sanofi Corporate Integrity Agreement (CIA), the Warner Chilcott settlements exploring the lessons to be learned. We also hear from a panel of five Chief Compliance Officers what life is like after the CIA ends. Finally, we have updates on key 1st Amendment and the Prevor combination products cases.

Table of Contents

Arrow

EDITOR’S CORNER: Back to the Future Compliance Style

Arrow

ENFORCEMENT: The Yates Memo: This seems all too familiar

Arrow

ENFORCEMENT: The New Gilded Age of Individual Accountability – Views from the Enforcers

Arrow

ENFORCEMENT: Sanofi (finally) signed their Corporate Integrity Agreement

Arrow

ENFORCEMENT: How not to move the needle – Lessons from the Warner Chilcott Settlement

Arrow

LEGISLATION: Bipartisan Budget Act Increases Civil Monetary Penalties

Arrow

COMPLIANCE OPS: Speaking Frankly – Post CIA Insights from Five Chief Compliance Officers

Arrow

FREE SPEECH: FDA v. the 1st Amendment – The Saga Continues

Arrow

ORPHAN DRUGS: Strike Two – HRSA’s 340B Orphan Drug Policy Struck Down Again

Arrow

MEDICAL DEVICES: Allowing Industry to Decide Its Own Regulatory Fate? Evaluating the Long-Term Significance of the Prevor Case

Arrow

BRIEFLY NOTEWORTHY

Menu Title